Nina Tunariu

12PUBLICATIONS
170CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Deep learningMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 27, 2026
Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma.

|Jan 09, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Jonathan Welti, Denisa Bogdan, Ines Figueiredo

|Feb 20, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.

Somaieh Hedayat, Luciano Cascione, David Cunningham

|Aug 19, 2022
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.

Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang

|Nov 10, 2021
HER3 Is an Actionable Target in Advanced Prostate Cancer.

Veronica Gil, Susana Miranda, Ruth Riisnaes

|Oct 07, 2021
Accelerating Whole-Body Diffusion-weighted MRI with Deep Learning-based Denoising Image Filters.

Konstantinos Zormpas-Petridis, Nina Tunariu, Andra Curcean

Pageof 2

Frequent Collaborators

6 joint publications

Johann S de Bono

5 joint publications

Udai Banerji

5 joint publications

Susana Miranda

4 joint publications

Veronica S Gil